ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

H1N1 Swine Flu Update - Guillain Barre Syndrome & Other Vaccine Fallout

Updated on November 28, 2009

The Centers For Disease Control & Prevention is expecting to release this report early in December and the virological and medical community is looking forward to this issuance as it will mark a turning point in the epidemiological research of H1N1. This report will give researchers a much better indication of what is occurring out in the field with H1N1 Mexican Swine Flu Virus and therefore, how to best counteract it.

With the limited data which has been collected to this point there are no unusual signals or strange adverse occurrences connected with either the seasonal vaccine for influenza or the specific vaccine against H1N1 that would be of a severity which would prompt the Centers for Disease Control and Prevention in Atlanta to recommend that interventions be taken urgently.

However the Centers For Disease Control & Prevention continues to monitor the situation on a minute by minute basis and turn over information on every event for evaluation to the Centers For Disease Control & Prevention's and National Institutes Of Health's clinical personnel in order to discover new patterns in the H1N1 virus's behaviour.

The Center for Disease Control & Prevention also has a variety of clinical system monitors in place that are actively seeking signs that the vaccine exposure has been directly responsible for various conditions which can be considered severe such as Guillain Barre Syndrome. The details are not yet unfortunately available but hopefully those details will be available in their full clinical version in the beginning of December 2009.

The surveys which have been conducted by various news organizations and medical organizations in the United States have been showing that the interest in vaccination among individuals in the target population has been steadily increasing and that parents are becoming more and more convinced that their children should be vaccinated. The single greatest problem facing vaccination acceptance in the United States is the concern by people who do not believe that the disease is not serious and will be believe that the vaccine may be unsafe.

The recent information from the Canadian Medical Health Authorities that a number of individuals who have received the H1N1 vaccine in that country have suffered severe allergic reactions as well as side effects and after effects from the administration of the vaccine have not yet been finalized. Therefore it cannot be determined as to whether the source of those ill effects are from the elements of the vaccine which is shared in common with the one used in the United States or whether it is a different form of vaccine that is used in Canada which is based on a adjuvanted formula. Again that information should be available in December.

The fact remains that a particular batch of H1N1 Mexican Swine Flu Virus vaccine that was shipped from Glaxo Smith Kline to various provinces in Canada has proven to cause a higher than average rate of reactions in the individuals who received that vaccine. The form of reaction is anaphylaxis and one man who had received a pandemic influenza H1N1 vaccine shot died shortly thereafter from anaphylaxis reaction. Investigations are currently being conducted by the Canadian government and Glaxo Smith Kline officials while the entire lot of vaccine has been destroyed. The lot consisted of 125,000 doses which were shipped to total of 6 Canadian provinces.

Continued In H1N1 Swine Flu Update - Canadian Vaccine & Anaphylaxis

Back To Start


Disclaimer: The information on this Hub page does not constitute medical, legal, commercial, product, and/or service advice or endorsement of any vendor, supplier and/or brand, and does not necessarily reflect the opinion of the author. Listing of an entity or service on this Hub page is not a warranty of the quality or efficacy of the products or services furnished by any entity. The author is not directly compensated by any entity other than the advertising placement services shown on this page.


    0 of 8192 characters used
    Post Comment

    No comments yet.